Cetera Investment Advisers Humacyte, Inc. Put Options Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HUMA
# of Institutions
167Shares Held
54.1MCall Options Held
1.1MPut Options Held
808K-
Vanguard Group Inc Valley Forge, PA7.52MShares$9.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.14MShares$9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$5.53 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$3.72 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.64MShares$3.33 Million0.01% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $130M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...